Brca2 abrogation engages with the alternative lengthening of telomeres via break‐induced replication

Mi‐Sun Kwon,Jennifer J. Lee,Jaewon Min,Kwangwoo Hwang,Seung Gu Park,Eun‐Hye Kim,Byung Chul Kim,Jong Bhak,Hyunsook Lee
DOI: https://doi.org/10.1111/febs.14796
2019-03-12
Abstract:<p>A subset of cancer cells maintain their telomeres without telomerase through the recombination‐based Alternative Lengthening of Telomeres (ALT) pathway. Currently, it is not yet clear in what context ALT is induced and how the pathway choice is made. Here, we show that abrogation of <i>Brca2</i> reinforces break‐induced replication (BIR) and engages with ALT pathway. Brca2 depletion in telomerase‐null mouse cells alleviated the growth defect, accompanied by telomere elongation, suggesting the induction of ALT. We also found that Brca2‐depleted telomerase‐null cells exhibited dynamic clustering of telomeres from G2 phase in Promyelocytic Nuclear (PML) bodies. For Brca2‐deficient ALT induction, Rad51 was dispensable but Mre11 and Rad52 were required. Congruently, conservative telomeric DNA synthesis was apparent in mitosis, indicating that the absence of Brca2 directed towards Rad52‐mediated BIR. Collectively, we propose that Brca2 abrogation can instigate ALT tumorigenesis through the induction of BIR. This study implies that inhibitors of BIR may be useful for BRCA2‐associated ALT‐type cancers. Assessing ALT features may be considered for the tailored therapy of BRCA2‐associated cancers.This article is protected by copyright. All rights reserved.</p>
biochemistry & molecular biology
What problem does this paper attempt to address?